Earlier this fall, when I was prescribed a 7-day course of antibiotics to clear up a persistent infection, I was pretty sure I'd ace the patient compliance exam.
An investigational antiviral used to treat life-threatening adenovirus and cyto-megalovirus (CMV) infections in transplant patients seems to be free of the side-effects associated with similar drugs.